Zonisamide: In Parkinson's Disease

Author： Yang Lily P.H.   Perry Caroline M.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.23, Iss.8, 2009-08, pp. : 703-711

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Zonisamide in Parkinson's Disease†: Profile Report

By Yang Lily P.H.   Perry Caroline M.  

Drugs & Aging, Vol. 27, Iss. 1, 2010-01 ,pp. : 73-75

Adis International

Access to resources Recommend Favorite

Disease Modification in Parkinson's Disease

By Henchcliffe Claire  

Drugs & Aging, Vol. 28, Iss. 8, 2011-08 ,pp. : 605-615

Adis International

Access to resources Recommend Favorite

Novel Therapeutic Effects of the Anti-Convulsant, Zonisamide, on Parkinson's Disease

By  

Current Pharmaceutical Design, Vol. 10, Iss. 6, 2004-02 ,pp. : 687-693

Bentham Science Publishers

Access to resources Recommend Favorite

Rivastigmine in Parkinson's disease dementia

By Chitnis Shilpa   Rao Jayaraman  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 941-955

Informa Healthcare

Access to resources Recommend Favorite

Nicotinic receptors and Parkinson's disease

By Quik M.   Jeyarasasingam G.  

European Journal of Pharmacology, Vol. 393, Iss. 1, 2000-03 ,pp. : 223-230

Elsevier

Access to resources Recommend Favorite